Forgetfulness is never just a simple matter of poor memory. When the hippocampus deep in the brain quietly atrophies due to hypoxia, when Aβ plaques silently accumulate between nerve cells, a person’s memory, personality, and dignity slip away inch by inch. This is not a natural phenomenon of aging, but Alzheimer’s disease. Many people dismiss early memory decline as normal aging and ignore it, only to miss the optimal intervention window by the time they can no longer recognize their own family. The hyperbaric oxygen chamber increases oxygen partial pressure in the blood, forces more oxygen into the hypoxic brain tissue, buys survival time for neurons, and treats Alzheimer’s disease.
What is Alzheimer’s Disease?
In the brain of an Alzheimer’s patient, two proteins are at work. One is beta-amyloid protein, which accumulates between neurons, forming plaques that clog the spaces between brain cells like garbage. The other is Tau protein, which becomes abnormally phosphorylated inside neurons, tangling like a disordered mass around the cell’s internal transport channels. Together, they cause neurons to gradually die, and the brain shrinks accordingly. The first region to be attacked is often the hippocampus, which governs memory.
Recent studies have found that hypoxia is not merely a concomitant phenomenon of AD, but an important driving factor in its onset. Hypoxia can promote the deposition of beta-amyloid protein, hyperphosphorylation of Tau protein, mitochondrial dysfunction, and oxidative stress, constituting potential triggers for AD and accelerating its pathological changes.
Have you ever seen an elderly person like this: smiling and talking to you one moment, forgetting your name the next; sitting in their own living room but insisting on going home; repeatedly telling stories from decades ago but not remembering what they just ate? The horror of Alzheimer’s disease lies in the fact that it never rushes. It moves slowly, but never turns back.
At first, it is just forgetting where you put your keys, or failing to recall a name you just heard. Gradually, patients begin to get lost frequently, repeat questions, and become irritable or indifferent. Later, they may not recognize the person in the mirror, or even forget how to dress, eat, or use the bathroom. This is a process from forgetting things to losing oneself—the brain is like pages being erased line by line with an eraser, until nothing is left.
Who is most commonly affected by Alzheimer’s disease? Age is the primary risk factor. Among people over 70, about 10% have Alzheimer’s disease. By age 85 and above, this proportion soars to about 25%. The prevalence in women is about 1.8 times that in men, which may be related to women’s longer life expectancy and changes in estrogen levels.
Currently, there is no truly effective drug for Alzheimer’s disease worldwide. Drugs such as cholinesterase inhibitors and glutamate receptor antagonists can only slow the rate of cognitive decline to a certain extent, but cannot reverse neuronal death that has already occurred. In contrast, non-pharmacological interventions have received increasing attention in recent years, and hyperbaric oxygen therapy is one of the most promising among them. More than 55 million people worldwide are experiencing this long farewell, and hyperbaric oxygen therapy is injecting new hope into this battle in a simple yet powerful way.
How Does a Hyperbaric Oxygen Chamber Treat Alzheimer’s Disease?
Hyperbaric oxygen therapy uses a hyperbaric environment to significantly increase the amount of physically dissolved oxygen in the blood, allowing this extra oxygen to travel directly with plasma to brain regions that are under-supplied with oxygen due to microcirculatory impairment. Consider an early-stage Alzheimer’s patient with mild memory decline who has already noticed frequent forgetfulness but can still live independently. After evaluation by a doctor, he begins using a home hyperbaric oxygen chamber at 1.5 ATA for 60 minutes daily.
HBOT promotes the clearance of Aβ plaques
It effectively reduces the deposition of Aβ plaques in the brain, lowers the accumulation of hyperphosphorylated Tau protein, and delays the degeneration of neurons and synapses, intervening in disease progression at the pathological level.
HBOT activates autophagy pathways
In a study on AD mice, the HBOT treatment group showed significantly improved cognitive function, and the expression of five autophagy-related genes in hippocampal tissue was significantly upregulated. Autophagy is an important mechanism for cells to clear waste proteins, and HBOT activates this pathway to help neurons clear accumulated Aβ.
HBOT improves brain tissue oxygenation and microcirculation
Long-term HBOT intervention can increase blood oxygen saturation, improve vascular structure and function, reduce neuroinflammation in the brain, and delay hippocampal volume atrophy.
| Study Subject | Intervention Protocol | Main Results | Source |
| AD Model Mice | 3-month HBOT intervention | Reduced A plaque deposition, decreased Tau aggregation, improved cognitive function | Redox Biology, 2024-8 |
| APP/PS1 AD Mice | HBOT | Shortened escape latency, prolonged target quadrant stay, upregulation of autophagy-related genes | Physiol Res, 2025-1 |
| Amnestic Mild Cognitive Impairment Patients | HBOT + conventional treatment vs conventional treatment | Study group MMSE score significantly higher than control group (28.42 vs 26.49), inflammatory factors significantly reduced | Systematic Medicine, 2025-5 |
| Early AD Patients | 3-month HBOT | Delayed hippocampal volume atrophy, clinical improvement in ADAS-Cog score | Annual Report of the Hyperbaric Oxygen Medicine Branch of the Chinese Medical Association, 2025 |
References:
HBOT improves cognitive function in AD mice via autophagy pathway. Physiol Res, 2025.
Global Alzheimer’s Disease Burden Report. PLoS One, 2025.
Effect of hyperbaric oxygen therapy on amnestic mild cognitive impairment in Alzheimer’s disease. Systematic Medicine, 2025.
Therapeutic effects of long-term HBOT on AD neuropathologies. Redox Biology, 2024.
Home Hyperbaric Chamber vs. Traditional Chamber?
Intervention for Alzheimer’s disease is never a problem that can be solved by a single hospital stay. It is a process that requires continuous management over years or even decades. Traditional hyperbaric oxygen chambers are concentrated in hospitals. If patients want to use HBOT to slow cognitive decline, they have to travel back and forth to the hospital repeatedly. For elderly individuals who already have limited mobility and declining cognitive function, this cost is too high. Registration, waiting, changing clothes, entering the chamber—half a day is gone, and family members must take time off work to accompany them.
Home hyperbaric chambers are changing this situation. Kingshare, as an original home hyperbaric chamber factory, has over a decade of manufacturing experience, a self-owned production base of over 2,000 square meters, and products sold both domestically and internationally. From rigid chambers to soft chambers, pressure from 1.3 to 2.0 ATA can be customized, truly enabling patients to complete each 60-minute oxygen therapy session at home without waiting in lines or traveling.
Compared with traditional medical hyperbaric chambers, the greatest value of home chambers lies in the possibility of long-term adherence. For AD patients, regular, sustained oxygen therapy intervention is more important than one-time intensive treatment. With a home hyperbaric chamber, patients can complete treatment in a familiar, safe environment—no smell of disinfectant, no strangers, no tension. For AD patients who are already prone to anxiety and confusion, this experience of being gently held is itself the best adjunctive therapy.
Kingshare’s attention to user experience is equally commendable. The chamber is equipped with a high-concentration negative ion system, and the water circulation heating and humidification system eliminates the dryness and cold of traditional chambers. The BIBS mask system improves oxygen utilization efficiency. The chamber can also be customized with red light therapy, which promotes cellular metabolism and accelerates tissue repair, working synergistically with HBOT.
We have abandoned the square, cold design of traditional oxygen chambers and adopted a cute, rounded shell shape inspired by the Hobbit’s fairytale cottage. It is not a cold medical device, but a personal rest station for the soul. The warm, bright interior breaks down the distance between the device and the user. For Alzheimer’s patients, stepping into such a fairytale-like space brings a sense of being gently held, rather than the pressure of being treated.
Real Case: When Oxygen Becomes the Guardian of Memory
Laura, a 72-year-old woman, was diagnosed with amnestic mild cognitive impairment related to Alzheimer’s disease—a transitional state between normal aging and Alzheimer’s, and the golden window for intervention. Her main symptoms were progressive memory decline, especially difficulty remembering recent events, along with mild executive dysfunction. On the basis of conventional treatment, she received a full course of HBOT: at 2.0 ATA, 90 minutes per session, five times weekly, for 12 consecutive weeks.
After 8 weeks of treatment, her family reported that she no longer repeated the same question frequently and could better remember what happened during the day. After completing the full 12-week course, she not only maintained stable cognitive function but also showed slight improvement in spatial orientation and verbal fluency. HBOT brought stabilization of cognitive function to this early-stage AD patient, extending her time of independent living.
When neurons deep in the brain slowly die in hypoxia and protein accumulation, giving them a little more oxygen may make this long farewell come a little later. Alzheimer’s disease is one of the most difficult fortresses for medicine to conquer. It is not cancer, yet it is more terrifying than many cancers, because what it takes away is not life itself, but all the memories, emotions, and dignity that make a person who they are. In this invisible war, hyperbaric oxygen therapy is using a gentle yet powerful way to buy more clear-headed time for those who are lost in forgetting.
It does not promise reversal or claim cure. It simply delivers an extra dose of oxygen to hypoxic neurons in every quiet 60-minute session, letting them hold on a little longer and letting memory loss slow down one step more. Whether it is a 2.5 ATA treatment chamber in a hospital or a 1.5 ATA maintenance chamber at home, they share the same essence: delivering what life needs most—oxygen—in the most reliable way, to where it is needed most—the brain. Forgetting may not be completely preventable, but we can try to make it come later and more slowly.
Kingshare is a hyperbaric oxygen chamber factory with 10 years of production experience. We provide turnkey services from design to delivery. If you have any needs for hyperbaric oxygen chambers, please contact us.
